Skip to main content

Siokas Grigorios's Form 4 filing

Cosmos Health Inc. (COSM) · filed Oct 24, 2022

Accession no.
0001477932-22-007869
Filed
Oct 24, 2022, 12:56 PM ET
Trade date
Oct 20, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 4 derivative transactions. Open-market purchases total $1.50M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Siokas GrigoriosCIK 0001660125Director, Officer (Chief Executive Officer), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 20, 2022Common Stock, $.001 par valuePPurchaseAcquired+12,500,000$0.12+$1,500,00019,334,168Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 20, 2022Common StockHLess common codeDisposed−2,654,782$0.6215−$1,649,947.010Direct
Oct 20, 2022Common StockPPurchaseAcquired+5,309,564$0.12+$637,147.685,309,564Direct
Oct 20, 2022Common StockPPurchaseAcquired+12,500,000$0.12+$1,500,00012,500,000Direct
Oct 20, 2022Common StockPPurchaseAcquired+12,500,000$0.12+$1,500,00012,500,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)